Search Results - "TU, Emily"

Post-Mortem Review and Genetic Analysis of Sudden Unexpected Death in Epilepsy (SUDEP) Cases by Tu, Emily, Bagnall, Richard D., Duflou, Johan, Semsarian, Christopher

“…Sudden unexpected death in epilepsy (SUDEP) is the most frequent epilepsy‐related cause of death and is characterized by an absence of any identifiable cause…”
Get full text

Factors Associated with Potentially Harmful Medication Prescribing in Nursing Homes: A Scoping Review by Lipori, Jessica P., Tu, Emily, Shireman, Theresa I., Gerlach, Lauren, Coe, Antoinette B., Ryskina, Kira L.

“…To summarize current evidence regarding facility and prescriber characteristics associated with potentially harmful medication (PHM) use by residents in…”
Get full text

Genetic Analysis of Hyperpolarization-Activated Cyclic Nucleotide-Gated Cation Channels in Sudden Unexpected Death in Epilepsy Cases by Tu, Emily, Waterhouse, Louise, Duflou, Johan, Bagnall, Richard D., Semsarian, Christopher

“…Sudden unexpected death in epilepsy (SUDEP) is the most common epilepsy‐related cause of death, yet the cause is unknown. Our previous studies suggest a role…”
Get full text

Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma by Kong, Benjamin Y, Sim, Hao-Wen, Barnes, Elizabeth H, Nowak, Anna K, Hovey, Elizabeth J, Jeffree, Rosalind, Harrup, Rosemary, Parkinson, Jonathon, Gan, Hui K, Pinkham, Mark B, Yip, Sonia, Hall, Merryn, Tu, Emily, Carter, Candace, Koh, Eng-Siew, Lwin, Zarnie, Dowling, Anthony, Simes, John S, Gedye, Craig

“…IntroductionGlioblastoma (GBM) is the most common malignant primary central nervous system cancer in adults. The objective of the Multi-Arm GlioblastoMa…”
Get full text

Post-mortem pathologic and genetic studies in “dead in bed syndrome” cases in type 1 diabetes mellitus by Tu, Emily, BSc, Bagnall, Richard D., PhD, Duflou, Johan, MBChB, FRCPA, Lynch, Matthew, FRCPA, Twigg, Stephen M., PhD, FRACP, Semsarian, Christopher, PhD, FRACP

“…Summary Dead in bed syndrome is a poorly understood cause of sudden death in young people with type 1 diabetes. The underlying cause remains unknown. One…”
Get full text

Severe Heart Failure and Early Mortality in a Double-Mutation Mouse Model of Familial Hypertrophic Cardiomyopathy by TSOUTSMAN, Tatiana, KELLY, Matthew, NG, Dominic C. H, TAN, Ju-En, TU, Emily, LAM, Lien, BOGOYEVITCH, Marie A, SEIDMAN, Christine E, SEIDMAN, J. G, SEMSARIAN, Christopher

“…Familial hypertrophic cardiomyopathy (FHC) is characterized by genetic and clinical heterogeneity. Five percent of FHC families have 2 FHC-causing mutations,…”
Get full text

Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy by Tsoutsman, Tatiana, Chung, Jessica, Doolan, Alessandra, Nguyen, Lan, Williams, Iwan A., Tu, Emily, Lam, Lien, Bailey, Charles G., Rasko, John E.J., Allen, David G., Semsarian, Christopher

“…Gene mutations in cardiac troponin I (cTnI) account for up to 5% of genotyped families with familial hypertrophic cardiomyopathy (FHC). Little is known about…”
Get full text

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer by Davis, Ian D, Martin, Andrew J, Stockler, Martin R, Begbie, Stephen, Chi, Kim N, Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E, Horvath, Lisa G, Joshua, Anthony M, Lawrence, Nicola J, Marx, Gavin, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A, Parnis, Francis, Parulekar, Wendy, Pook, David W, Reaume, M. Neil, Sandhu, Shahneen K, Tan, Alvin, Tan, T. Hsiang, Thomson, Alastair, Tu, Emily, Vera-Badillo, Francisco, Williams, Scott G, Yip, Sonia, Zhang, Alison Y, Zielinski, Robert R, Sweeney, Christopher J

“…In men with metastatic, hormone-sensitive prostate cancer who were receiving testosterone suppression, the addition of enzalutamide led to significantly longer…”
Get full text

Nursing Home Compare star ratings before versus after a change in nursing home ownership by Ryskina, Kira L., Tu, Emily, Liang, Junning, Kim, Seiyoun, Werner, Rachel M.

“…Background Efforts to increase transparency and accountability of nursing homes, and thus improve quality, now include information about changes in nursing…”
Get full text

Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy by Sweeney, Christopher J., Martin, Andrew J., Stockler, Martin R., Begbie, Stephen, Chi, Kim N., Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E., Horvath, Lisa G., Joshua, Anthony M., Lawrence, Nicola J., Marx, Gavin M., McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A., Parnis, Francis, Parulekar, Wendy, Pook, David W., Reaume, M. Neil, Sandhu, Shahneen K., Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Tu, Emily, Vera-Badillo, Francisco, Williams, Scott G., Yip, Sonia, Zhang, Alison Y., Zielinski, Robert R., Davis, Ian D.

“…Men who initially present with localized prostate cancer and later develop metachronous metastases have a better prognosis than men with de novo metastatic…”
Get full text

Automated Femoral Landmark Detection from Pelvic X-Rays by Statchen, Thomas, Choi, Grace, Gao, Charis, Xu, Winnie, Rajapakse, Chamith, Hao, Leilei, Ranaweera, Dilini, Lee, Charis June, Tu, Emily, Basu, Anika

“…Surgical planning requires the identification of anatomical landmarks on medical images pre, intra, and post-procedures. Landmark detection on X-rays is thus…”
Get full text

Sudden death in type 1 diabetes: The mystery of the ‘dead in bed’ syndrome by Tu, Emily, Twigg, Stephen M, Semsarian, Christopher

“…Abstract Sudden cardiac death is an unpredictable and devastating event, particularly in the young. A significant proportion of sudden deaths in the young are…”
Get full text

RTID-05. THE MULTI-ARM GLIOBLASTOMA AUSTRALASIA (MAGMA) TRIAL by Kong, Benjamin, Sim, Hao-Wen, Koh, Eng-Siew, Gan, Hui, Barnes, Elizabeth H, Yip, Sonia, Nowak, Anna K, Lau, Peter, Cuff, Katharine, Khoo, Eric, Lwin, Zarnie, Cooper, Adam, Dowling, Anthony, Linton, Anthony, Harrup, Rosemary, Dunlop, Tracey, Hovey, Elizabeth, Parkinson, Jonathon, Jeffree, Rosalind, Hall, Merryn, Tu, Emily, Andrew, Diana, Simes, John, Gedye, Craig

“…Abstract BACKGROUND Survival outcomes for patients with newly diagnosed glioblastoma have not changed significantly since the introduction of concurrent…”
Get full text

INNV-08. LOW AND INTERMEDIATE GRADE GLIOMA UMBRELLA STUDY OF MOLECULAR GUIDED THERAPIES (LUMOS) STUDY by Kong, Benjamin, Sim, Hao-Wen, Amanuel, Benhur, Day, Bryan, Buckland, Michael, Verhaak, Roel, Yip, Sonia, Johns, Terrance, Lwin, Zarnie, Rosenthal, Mark, Nowak, Anna K, Barnes, Elizabeth H, Scott, Andrew M, Parkinson, Jonathon, Jeffree, Rosalind, Lourenco, Richard De Abreu, Lau, Peter, Whittle, James, Hovey, Elizabeth, Cher, Lawrence, Kichendasse, Ganessan, Hall, Merryn, Robinson, Cleo, Thomas, Marc, Giardina, Tindaro, Tu, Emily, Khasraw, Mustafa, Koh, Eng-Siew, Gan, Hui

“…Abstract BACKGROUND Grade 2 and 3 (G2/3) gliomas are the second largest group of brain tumors in adults. Although the prognosis for G2/3 gliomas at the time of…”
Get full text

Randomised phase III trial of enzalutamide in androgen deprivation therapy (ADT) with radiation therapy for clinically localised, high risk, or node-positive prostate cancer: ENZARAD (ANZUP 1303) by Williams, Scott, Davis, Ian D., Sweeney, Christopher, Stockler, Martin R., Martin, Andrew James, Hague, Wendy, Coskinas, Xanthi, Yip, Sonia, Tu, Emily, Lawrence, Nicola Jane, McDermott, Ray, Kelly, Paul J., Deignan, Olwyn, Hughes, Simon, Fonteyne, Valerie, Tombal, Bertrand F., Nguyen, Paul L.

“…Abstract only TPS5096 Background: Adjuvant ADT with an LHRH analog (LHRHA) given before, during and after radiotherapy (RT) is standard of care for high risk…”
Get full text

Randomised phase 3 trial of enzalutamide in androgen deprivation therapy (ADT) with radiation therapy for high risk, clinically localized prostate cancer: ENZARAD (ANZUP 1303) by Williams, Scott, Davis, Ian D., Sweeney, Christopher, Stockler, Martin R., Martin, Andrew James, Hague, Wendy, Coskinas, Xanthi, Yip, Sonia, Tu, Emily, Lawrence, Nicola Jane, Nayar, Namrata, McDermott, Ray, Kelly, Paul, Deignan, Olwyn, Hughes, Simon, Fonteyne, Valerie, Tombal, Bertrand F., Nguyen, Paul L.

“…Abstract only TPS156 Background: Adjuvant ADT with an LHRH analog (LHRHA) given before, during and after radiotherapy (RT) is standard of care for high risk…”
Get full text

Causes of death in young Australians with type 1 diabetes: a review of coronial postmortem examinations by Tu, Emily, Twigg, Stephen M, Duflou, Johan, Semsarian, Christopher

“…Objective: To determine the causes of death in Australians with type 1 diabetes mellitus who died aged 40 years or younger. Design and setting: Retrospective…”
Get full text

LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study by Kong, Benjamin Y, Sim, Hao-Wen, Nowak, Anna K, Yip, Sonia, Barnes, Elizabeth H, Day, Bryan W, Buckland, Michael E, Verhaak, Roel, Johns, Terrance, Robinson, Cleo, Thomas, Marc A, Giardina, Tindaro, Lwin, Zarnie, Scott, Andrew M, Parkinson, Jonathon, Jeffree, Rosalind, Lourenco, Richard de Abreu, Hovey, Elizabeth J, Cher, Lawrence M, Kichendasse, Ganessan, Khasraw, Mustafa, Hall, Merryn, Tu, Emily, Amanuel, Benhur, Koh, Eng-Siew, Gan, Hui K

“…IntroductionGrades 2 and 3 gliomas (G2/3 gliomas), when combined, are the second largest group of malignant brain tumours in adults. The outcomes for G2/3…”
Get full text

Randomised phase 3 trial of enzalutamide in androgen deprivation therapy (ADT) with radiation therapy for clinically localised high-risk or node-positive prostate cancer: ENZARAD (ANZUP 1303) by Williams, Scott G., Davis, Ian D., Sweeney, Christopher, Stockler, Martin R., Martin, Andrew James, Hague, Wendy, Coskinas, Xanthi, Yip, Sonia, Tu, Emily, Chan, Howard, Lawrence, Nicola Jane, McDermott, Ray, Hughes, Simon, Marchesin, Vittorio, Deignan, Olwyn, Nguyen, Paul L.

“…Abstract only…”
Get full text

Randomised phase 3 trial of enzalutamide in first-line androgen deprivation therapy for metastatic prostate cancer: The ANZUP ENZAMET Trial (ANZUP 1304) by Davis, Ian D., Stockler, Martin R., Martin, Andrew James, Hague, Wendy, Coskinas, Xanthi, Yip, Sonia, Tu, Emily, Lawrence, Nicola Jane, Chan, Howard, McDermott, Ray, Chowdhury, Simon, Marchesin, Vittorio, Deignan, Olwyn, Vera-Badillo, Francisco, North, Scott A., Montenegro, Alexander, Sweeney, Christopher

“…Abstract only…”
Get full text